Login to Your Account



BioWorld Insight

The weekly news service that provides behind-the-scenes analysis and commentary on the biopharmaceutical marketplace.
 
 

BioWorld Insight analyzes critical components of the biopharma industry, from insights into which products are ahead or behind in a particular product space, the potential impact of new and pending regulatory rules and ideas for generating capital funding that is the lifeblood of the industry.

Every Monday – you'll have the behind-the-scenes analysis plus:

  • Our BioWorld Stock Report for U.S. publicly traded companies, listings for the London and Toronto stock exchanges, plus the 10 biggest gainers and losers for the week.

  • Find out who is ahead in niche markets, new and pending regulation, and ideas for generating the capital that is the lifeblood of the industry.

  • Insight examines business challenges – and potential solutions – that constantly face both industry giants and brand new start-ups.

Inside each issue – our exclusive charts and graphs to key biopharma metrics – available nowhere else:

  • Clinical trial updates separated by indication (cancer, diabetes, etc.), plus FDA actions

  • Details of collaborations and deal modifications

  • manufacturing agreements

  • Public financing and private

  • Public offering performance by underwriters

  • FDA actions

BioWorld Insight – the analytical companion to BioWorld Today for executives who demand the winning edge!

To place an order: Call 1-800-477-6307 or 1-770-810-3144 (Outside the U.S.) or email BioWorld.salessupport@thomsonreuters.com.